MRNA upgraded to Neutral by BAML
Hammerstone MarketTalk reports that BAML upgraded MRNA to a Neutral rating, with no further details on target, catalyst, or timing provided in the feed.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.